VBP

The 3 year survival rate of 9 patients who had received VBP chemotherapy suggested by chemosensitivity was 66.7%, and of 5 patients received VAP treatment, it was 53.3%.

根据药敏结果，9例上皮性卵巢癌使用VBP方案化疗，3年生存率66.7%，5例使用VAP方案者3年生存率53.3%。

互联网摘选

The median IRs of VBP and VAP to specific histology of epithelial ovarian cancer ( EOC) were 77.3% and 71.0%, respectively.

VBP、VAP方案对上皮性卵巢癌的中位抑制率分别为77.3%和71.0%。

互联网摘选